ASIAPHARM Group, a China-based specialty pharmaceutical group that is listed on the Singapore mainboard, said its wholly owned subsidiary, Shandong Luye Pharmaceutical, will be supplying pharmaceutical products to the Vietnamese market. It will initially launch two of its key products, Maitongna and Lutingnuo, in the first quarter of next year.